N-Power Medicine — Kaleido Registry (ex-Syapse)
N-Power Medicine
N-Power Medicine runs the Kaleido Registry, a consented prospective data-collection programme across a community oncology network, which absorbed Syapse's oncologist network and data assets in its December 2024 acquisition. Pharmaceutical sponsors use the research-ready patient data for trial recruitment and prospective external control arms under a commercial agreement.
Category
Commercial provider
Access
By application
Region
US
Data types
EHR, prospective registry, oncology records